Novartis (NVS) Tops on Q2 Earnings, Ups Operating Income View
Novartis(NVS) ZACKS·2024-07-18 21:25
Swiss pharma giant Novartis AG (NVS) reported better-than-expected results for the second quarter of 2024. Core earnings (excluding one-time charges) of $1.97 per share beat the Zacks Consensus Estimate of $1.87 and were up from $1.69 reported a year ago. The year-over-year growth was driven by an increase in sales.Revenues of $12.5 billion climbed 9% from the year-ago quarter’s figure. On a constant currency basis, sales increased 11%, driven by momentum in Entresto, Kesimpta, Kisqali, Cosentyx, Pluvict ...